These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
497 related items for PubMed ID: 20079141
1. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice. Ren JP, Zhao YW, Sun XJ. Chin Med J (Engl); 2009 Oct 05; 122(19):2366-71. PubMed ID: 20079141 [Abstract] [Full Text] [Related]
2. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice. Li X, Yin J, Cheng CM, Sun JL, Li Z, Wu YL. Chin Med J (Engl); 2005 Aug 20; 118(16):1357-61. PubMed ID: 16157030 [Abstract] [Full Text] [Related]
3. Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice. Kang MJ, Gil SJ, Koh HC. Toxicol Lett; 2009 Jul 24; 188(2):148-52. PubMed ID: 19446248 [Abstract] [Full Text] [Related]
7. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice. Minnema DJ, Travis KZ, Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck MJ, Mathews JM, Tisdel MO, Cook AR, Botham PA, Smith LL. Regul Toxicol Pharmacol; 2014 Mar 24; 68(2):250-8. PubMed ID: 24389362 [Abstract] [Full Text] [Related]
8. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice. Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck M, Mathews JM, Tisdel MO, Minnema D, Travis KZ, Cook AR, Botham PA, Smith LL. Neurotoxicology; 2013 Jul 24; 37():1-14. PubMed ID: 23523781 [Abstract] [Full Text] [Related]
10. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Mu X, He GR, Yuan X, Li XX, Du GH. Pharmacol Biochem Behav; 2011 Apr 24; 98(2):286-91. PubMed ID: 21262257 [Abstract] [Full Text] [Related]
11. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse. Przybyłkowski A, Kurkowska-Jastrzebska I, Joniec I, Ciesielska A, Członkowska A, Członkowski A. Brain Res; 2004 Sep 03; 1019(1-2):144-51. PubMed ID: 15306248 [Abstract] [Full Text] [Related]
12. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Jourdain S, Morissette M, Morin N, Di Paolo T. J Neuroendocrinol; 2005 Aug 03; 17(8):509-17. PubMed ID: 16011487 [Abstract] [Full Text] [Related]
13. Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine. Sharma A, Kaur P, Kumar V, Gill KD. Cell Mol Biol (Noisy-le-grand); 2007 Apr 15; 53(1):48-55. PubMed ID: 17519111 [Abstract] [Full Text] [Related]
14. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease. Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX. Neuroscience; 2008 May 15; 153(3):634-44. PubMed ID: 18420351 [Abstract] [Full Text] [Related]
15. Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo. Liou HH, Chen RC, Chen TH, Tsai YF, Tsai MC. Toxicol Appl Pharmacol; 2001 Apr 01; 172(1):37-43. PubMed ID: 11264021 [Abstract] [Full Text] [Related]
18. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease]. Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H. Zhongguo Zhong Yao Za Zhi; 2014 May 01; 39(9):1660-5. PubMed ID: 25095380 [Abstract] [Full Text] [Related]
19. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity. Himeda T, Kadoguchi N, Kamiyama Y, Kato H, Maegawa H, Araki T. Neuropharmacology; 2006 Mar 01; 50(3):329-44. PubMed ID: 16303147 [Abstract] [Full Text] [Related]